Human papillomavirus vaccines. WHO position paper.
نویسنده
چکیده
This is the first WHO position paper on vaccines against diseases caused by human papillomaviruses (HPVs). To complement the text and the selected references offered in this document, a comprehensive WHO background paper provides additional information and references reflecting evidence available to the end of September 2008 [1]. The final section of this position paper provides links to 5 grading tables for scientific evidence and their accompanying references.
منابع مشابه
References Human papillomavirus vaccines: WHO position paper, May 2017 (References with abstracts cited in the position paper in the order of appearance.) SAGE guidance for the development of evidence-based vaccine-related recommendations
BACKGROUND: Baseline information on human papillomavirus (HPV) prevalence and type distribution is highly desirable to evaluate the impact of prophylactic HPV vaccines in the near future. METHODS: A meta-analysis was performed of studies published between 1995 and 2009 that used polymerase chain reaction or Hybrid Capture 2 for HPV detection in women with normal cytological findings. RESULTS: T...
متن کاملFostering acceptance of human papillomavirus vaccines.
Multivalent prophylactic human papillomavirus (HPV) vaccines currently in the late stages of clinical testing are safe, immunogenic, and efficacious; and phase 3 tests of a quadrivalent vaccine show that it is 100% effective at preventing HPV types 16 and 18-associated cervical intraepithelial neoplasia grades 2 and 3, adenocarcinoma in situ, and cervical cancer through 2 years of postvaccinati...
متن کاملProphylactic Human Papilloma Virus Vaccines
Human papillomaviruses are the primary etiologic agents of cervical cancer. Thus, cervical cancer and other Human papillomavirus associated malignancies might be prevented by Human papillomavirus vaccines. Currently, two Human papillomavirus L1 Virus -Like Particle vaccines namely Gardasil quadrivalent (Merck) and CervarixTM bivalent (GlaxoSmithKline) are widely marketed internationally. These ...
متن کاملHuman papillomavirus genotype 16 pseudovirus production and purification in HEK-293FT cells
Introduction: Human papillomavirus (HPV) is the main causative agent of cervical cancer worldwide leading to a big health problem, especially in the developing countries. Among 14 common high-risk genotypes, HPV16 accounts for more than 50% of all cervical cancers. The current prophylactic vaccines against HPV infection are based on L1 protein. Due to some drawbacks in the current vaccines such...
متن کاملPreventive and Therapeutic Vaccines against Human Papillomaviruses Associated Cervical Cancers
Cervical cancer is, globally known to be, one of the most common cancers among women especially indeveloping countries. More than 90% of cervical cancers are associated with high-risk humanpapillomaviruses (HPVs) particularly HPV types 16 and 18. Two major strategies have been developed forprevention and treatment of cervical cancer and other HPV-associated malignancies; the first one is based ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Releve epidemiologique hebdomadaire
دوره 84 15 شماره
صفحات -
تاریخ انتشار 2009